Monte-G HC Interactions
There are 583 drugs known to interact with Monte-G HC (guaifenesin/hydrocodone), along with 16 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 211 are major, 371 are moderate, and 1 is minor.
- View all 583 medications that may interact with Monte-G HC
- View Monte-G HC alcohol/food interactions (1)
- View Monte-G HC disease interactions (16)
Most frequently checked interactions
View interaction reports for Monte-G HC (guaifenesin / hydrocodone) and the medicines listed below.
- albuterol
- allopurinol
- Ambien (zolpidem)
- amitriptyline
- amlodipine
- amoxicillin
- aspirin
- atenolol
- atropine
- baclofen
- bisoprolol
- cetirizine
- clopidogrel
- Crestor (rosuvastatin)
- Deep Sea Nasal Spray (sodium chloride nasal)
- Diamox (acetazolamide)
- doxycycline
- Dulera (formoterol / mometasone)
- Excedrin Migraine (acetaminophen / aspirin / caffeine)
- famotidine
- Flovent HFA (fluticasone)
- fluconazole
- fluticasone nasal
- furosemide
- gabapentin
- Glucophage (metformin)
- hydrochlorothiazide / lisinopril
- hydroxyzine
- ibuprofen
- metformin
Monte-G HC alcohol/food interactions
There is 1 alcohol/food interaction with Monte-G HC (guaifenesin / hydrocodone).
Monte-G HC disease interactions
There are 16 disease interactions with Monte-G HC (guaifenesin / hydrocodone) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
More about Monte-G HC (guaifenesin / hydrocodone)
- Monte-G HC consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.